Monotherapy for nonvalvular A-fib with stable CAD? A meta-analysis found oral anticoagulant (OAC) monotherapy provided efficacy comparable to OAC plus single antiplatelet therapy--with lower bleeding risk

The article discusses the meta-analysis found oral anticoagulant (OAC) monotherapy provided efficacy comparable to OAC plus single antiplatelet therapy with lower bleeding risk. Topics include decline in the number of influenza-positive clinical samples reported to the Centers for Disease Control and Prevention (CDC);and advice on co-administration with COVID-19 vaccines, and the list of contraindications and precautions based on vaccine type.